Table 1 Demographic data for control and MMD patients
From: Immune response profiling identifies autoantibodies specific to Moyamoya patients
| Â | Discovery set (20 sera) | Validation set (68 sera) | ||||
|---|---|---|---|---|---|---|
Protein arrays analysis | Cross sectional ELISA | |||||
Healthy control | MMD | CVD control | MMD | |||
|  | n = 10 | n = 10 | P value | n = 22 | n = 46 | P value |
Gender: males (%) | 40 | 60 | 0.61 | 45 | 26 | 0.03 |
Age (yr) | 29.6 ± 12.2 | 27.8 ± 10.7 | 0.73 | 49.1 ± 21.6 | 40.7 ± 13.6 | 0.10 |
Ethnicity% (1/2/3/4) †| 30/60/10/0 | 20/80/0/0 | 0.66 | 59/36/0/5 | 54/28/9/9 | 0.45 |
(MMD) Unilateral/bilateral | na | 0/5 | na | na | 24/22 | na |